SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Xerium Technologies, Inc. (XRM) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 31/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XRM
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.46
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.90
Book Value / Share$0.00
Revenue / Share$29.54
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2008 |
$11.60 |
$638.14M |
$26.6M |
4.2% |
| 2009 |
$-45.80 |
$500.09M |
$-111.99M |
-22.4% |
| 2010 |
$-7.29 |
$548.33M |
$-73.09M |
-13.3% |
| 2011 |
$0.54 |
$586.96M |
$8.19M |
1.4% |
| 2012 |
$-1.18 |
$538.74M |
$-18.04M |
-3.3% |
| 2013 |
$0.26 |
$546.89M |
$4.15M |
0.8% |
| 2014 |
$-0.48 |
$542.93M |
$-7.38M |
-1.4% |
| 2015 |
$-0.28 |
$477.24M |
$-4.38M |
-0.9% |
| 2016 |
$-1.35 |
$471.32M |
$-21.62M |
-4.6% |
| 2017 |
$-0.90 |
$481.05M |
$-14.65M |
-3% |
